|
| |
|
|
Viewed |
PDF |
Cited |
|
| SYMPOSIUM |
|
| Cost of clinical trials in India
S Agarwala
January-March 1973, 5(5):72-74 Full text not available [PDF] |
| 1,514 | 317 | - |
|
|
| Molecular modification in drug design
MD Nair
January-March 1973, 5(5):1-13 Full text not available [PDF] |
| 1,135 | 194 | - |
|
|
| Scope for investigating new indications for old drugs
EJ Vaz
January-March 1973, 5(5):62-63 Full text not available [PDF] |
| 1,022 | 81 | - |
|
|
| Methodological consideration in plasma level estimations
TG Rajagopalan
January-March 1973, 5(5):29-34 Full text not available [PDF] |
| 947 | 119 | - |
|
|
| Dose-response studies in man
RD Kulkarni
January-March 1973, 5(5):40-42 Full text not available [PDF] |
| 933 | 109 | - |
|
|
| Drug combinations
KG Nair
January-March 1973, 5(5):87-89 Full text not available [PDF] |
| 927 | 95 | - |
|
|
| Problem of extrapolating animal findings to man with special reference to diuretics
BV Shetty
January-March 1973, 5(5):22-24 Full text not available [PDF] |
| 897 | 105 | - |
|
|
| Pitfalls in the interpretation of clinical trial data
SM Shanbhag
January-March 1973, 5(5):64-67 Full text not available [PDF] |
| 893 | 104 | - |
|
|
| Evaluation of drugs in pregnant women
RH Choksi
January-March 1973, 5(5):48-56 Full text not available [PDF] |
| 862 | 132 | - |
|
|
| Correlation between plasma levels and drug responses
SV Gokhale
January-March 1973, 5(5):35-39 Full text not available [PDF] |
| 893 | 91 | - |
|
|
|
| SYMPOSIUM |
|
| Legislation and therapeutics
NH Wadia
January-March 1973, 5(5):94-96 Full text not available [PDF] |
| 900 | 67 | - |
|
|
|
| SYMPOSIUM |
|
| A critical appraisal of some test systems used in the preclinical evaluation of psychotropic activity
J David
January-March 1973, 5(5):14-21 Full text not available [PDF] |
| 859 | 99 | - |
|
|
| Conceiving a new product project
SK Bhattacharya
January-March 1973, 5(5):68-71 Full text not available [PDF] |
| 871 | 77 | - |
|
|
| Measurement and analysis of subjective response
AS Nanivadekar
January-March 1973, 5(5):43-47 Full text not available [PDF] |
| 861 | 79 | - |
|
|
| Impact of legislation on therapeutics
HM Lal
January-March 1973, 5(5):90-93 Full text not available [PDF] |
| 861 | 76 | - |
|
|
| The value of biochemical monitoring in clinical pharmacology
AB Vaidya
January-March 1973, 5(5):25-28 Full text not available [PDF] |
| 830 | 101 | - |
|
|
| Evaluation of drugs in children
JM Master
January-March 1973, 5(5):57-61 Full text not available [PDF] |
| 821 | 100 | - |
|
|
| Financing drug research in today’s socio-economic climate
DJ Mehta
January-March 1973, 5(5):75-79 Full text not available [PDF] |
| 852 | 67 | - |
|
|
| Effect of legislation on therapeutics
AS Nanivadekar
January-March 1973, 5(5):97-99 Full text not available [PDF] |
| 851 | 63 | - |
|
|
| Legislation and therapeutics
MK Ranganekar
January-March 1973, 5(5):84-86 Full text not available [PDF] |
| 802 | 69 | - |
|
|
| Impact of legislation on therapeutics
BB Gaitonde
January-March 1973, 5(5):80-83 Full text not available [PDF] |
| 781 | 64 | - |
|
|
